Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Sales6848841 0521 1461 2421 398
EBITDA161231289316355401
Operating profit (EBIT)120185226257291336
Pre-Tax Profit (EBT)105170213256291332
Net income72,5139177175198231
P/E ratio34,239,031,231,727,124,3
EPS ( € )0,791,511,921,972,302,57
Dividend per Share ( € )0,220,330,420,440,640,60
Yield0,81%0,56%0,70%0,70%1,03%0,96%
Reference price ( € )26.883358.959.9762.4562.4562.45
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Debt87,486,459,010263,4-
Finance-----20,8
Operating income (EBITDA)161231289316355401
Leverage
(Debt/EBITDA)
0,54x0,37x0,20x0,32x0,18x-
Capital Expenditure47,153,079,7116117104
Book Value Per Share (BVPS)5,78 €6,96 €8,22 €9,81 €11,6 €13,7 €
Cash Flow per Share1,21 €1,52 €1,70 €2,45 €2,78 €3,13 €
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 5 757 M€ -
Entreprise Value (EV) 5 859 M€ 5 820 M€
Valuation 2017e 2018e
P/E ratio (Price / EPS) 31,7x 27,1x
Capitalization / Revenue 5,02x 4,63x
EV / Revenue 5,11x 4,68x
EV / EBITDA 18,5x 16,4x
Yield (DPS / Price) 0,70% 1,03%
Price to book (Price / BVPS) 6,36x 5,39x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 22,5% 23,4%
operating Leverage (Delta EBIT / Delta Sales) 1,55x 1,55x
Net Margin (Net Profit / Revenue) 15,2% 15,9%
ROA (Net Profit / Asset) 12,0% 12,4%
ROE (Net Profit / Equities) 20,9% 19,9%
Rate of Dividend 22,1% 27,9%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   10,1% 9,38%
Cash Flow / Sales 19,7% 20,6%
Capital Intensity (Assets / Sales) 1,27x 1,28x
Financial Leverage (Net Debt / EBITDA) 0,32x 0,18x
EPS & Dividend